Pulmonary Hypertension: Intensification and Personalisation of Combination Rx — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pulmonary Hypertension: Intensification and Personalisation of Combination Rx — Stella

Recruiting

Back to Pulmonary Arterial Hypertension trials

Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.

Trial locations(1 site)

United Kingdom

Sheffield Teaching Hospitals NHS FT, Sheffield

Key details

Phase

Post-approval monitoring

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust

Collaborators

University of Glasgow, University of Sheffield

Enrollment target

~40 participants

Started

June 2023

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov